GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Asset Impairment Charge

K Pharma (TSE:4896) Asset Impairment Charge : 円0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Asset Impairment Charge?

K Pharma's Asset Impairment Charge for the three months ended in Mar. 2024 was 円0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil.

K Pharma Asset Impairment Charge Historical Data

The historical data trend for K Pharma's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Asset Impairment Charge Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Asset Impairment Charge
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

K Pharma Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

K Pharma Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of K Pharma's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Asset Impairment Charge
Comparable Companies
TSE:7776 TSE:4888 TSE:4594 TSE:4598 TSE:4588 TSE:4891 TSE:2370 TSE:3750 TSE:4583 TSE:4564 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
Website
https://en.kpharma.co.jp
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines